Ursodeoxycholic Acid 450 mg Sustained Release Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ursodeoxycholic Acid 450 mg Sustained Release Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: UDCA SR (Once-Daily)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ursodeoxycholic Acid 450 mg Sustained Release Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ursodeoxycholic Acid 450 mg Sustained Release Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ursodeoxycholic Acid 450 mg Sustained Release Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ursodeoxycholic Acid 450 mg Sustained Release formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Chronic PBC (twice-daily SR)
- Improved compliance in long-term therapy
Mechanism of Action
Ursodeoxycholic Acid (UDCA) is a hydrophilic bile acid that competitively displaces toxic hydrophobic bile acids from enterohepatic circulation — protects hepatocytes, improves bile flow, and dissolves cholesterol gallstones. First-line for primary biliary cholangitis.
Dosage & Administration
- Adults: 450 mg SR twice daily.
Side Effects
- Diarrhoea, nausea, hair thinning (long-term), GI upset.
Contraindications
- Acute cholecystitis, biliary obstruction, severe hepatic disease (advanced PBC), pigment gallstones, calcified gallstones.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Ursodeoxycholic Acid 450 mg Sustained Release Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ursodeoxycholic Acid 450 mg Sustained Release Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ursodeoxycholic Acid 450 mg Sustained Release Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ursodeoxycholic Acid 450 mg Sustained Release Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ursodeoxycholic Acid 450 mg Sustained Release Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ursodeoxycholic Acid 450 mg Sustained Release Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Ursodeoxycholic Acid 450 mg Sustained Release Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ursodeoxycholic Acid 450 mg Sustained Release Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Ursodeoxycholic Acid 450 mg Sustained Release Tablet?
MRPs range from ₹4500 to ₹4500 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ursodeoxycholic Acid 450 mg Sustained Release Tablet?